undefined undefined
NaN.000
NaN.00%
Gainers: AC Immune (ACIU) +51% Q1 earnings call release Gamestop Corporation (GME) +29% surges premarket as rally continues into Monday Cyclacel Pharmaceuticals (CYCC) +17%. Plutonian Acquisition (...
05-13 20:23
Incyte (NASDAQ:INCY) Board of Directors approved a share repurchase authorization of $2B. The company has commenced a modified “Dutch Auction” tender offer to repurchase shares of its common stock for...
05-13 20:04
MacroGenics press release (NASDAQ:MGNX): Q1 GAAP EPS of -$0.84 misses by $0.19. Revenue of $9.1M (-62.9% Y/Y) misses by $5.76M. Total revenue was $9.1 million for the quarter ended March 31, 2024, com...
05-10 04:29
美国旧金山和中国苏州2024年5月9日 /美通社/ -- 信达生物制药集团(香港联交所股票代码:01801),一家致力于研发、生产和销售肿瘤、自身免疫、代谢及心...
05-09 08:00
In the ever-evolving and intensely competitive business landscape, conducting a...
05-02 23:00
Truist Securities:重申Incyte(INCY.US)评级,由买入调整至买入评级, 目标价由84.00美元调整至83.00美元。
05-01 20:50
Companies in the Healthcare sector have received a lot of coverage today as ana...
05-01 12:40
Incyte shares are trading lower following a Q1 earnings miss.
04-30 21:11
Incyte (NASDAQ:INCY) reported quarterly earnings of $0.64 per share which missed the analyst consensus estimate of $0.84 by 23.81 percent. This is a 72.97 percent increase over earnings of $0.37 per share from the same
04-30 19:02
MorphoSys press release (NASDAQ:MOR): Q1 GAAP EPS of €8.27 Revenue of €27.5M, vs. €24.3M a year ago Full Year 2024 Financial Guidance: As a consequence of the sale and transfer of tafasitamab to Incyt...
04-30 04:55